United States · Business magazines · Quartz

Apothecary Pharma is recalling 22 vials of weight loss drug over sterility concerns

Published by Quartz · United States 2 h ago

The company received an FDA warning letter in December 2025 citing deficiencies in how it makes sterile drug products

Read the full article on Quartz Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (qz.com)

Also worth reading

The Hidden Costs of Covered-Call ETFs

No wonder the White House wants Warsh to cut: A 1% Fed rate hike costs the Treasury an extra $95 billion a year in national debt interest

Alexa von Tobel’s Inspired Capital Backed 10 Unicorns. Its New $450 Million Fund Targets 1 Kind of Founder

‘You Can See Everything’ perfectly captures what a decade of post-truth has done to us

Millennials Are Satisfied At Work Because They Stopped Expecting More

Take your drinks on a bus to the Chiefs game